Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Virology Journal

Volumn 9, Issue , 2012, Pages

  Wang, Bin ^a,b   Yu, Hai ^a   Yang, Fu Ru ^a   Huang, Meng ^a   Ma, Ji Hong ^a   Tong, Guang Zhi ^a,b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

Consensus HA; CTL epitope; DNA vaccine; M2e; Swine influenza

Indexed keywords

ANTIGEN MATRIX 2 ECTODOMAIN; DNA VACCINE; EPITOPE; H3 HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ; SWINE INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PATHOGENESIS; SWINE INFLUENZA; VIRUS STRAIN;

ANIMALS; DISEASE MODELS, ANIMAL; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; SWINE DISEASES; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL LOAD; VIRAL MATRIX PROTEINS;

MUS; SUIDAE; SWINE INFLUENZA VIRUS;

EID: 84862742968     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-127     Document Type: Article

References (45)

1. Dual infections of feeder pigs with porcine reproductive and respiratory syndrome virus followed by porcine respiratory coronavirus or swine influenza virus: a clinical and virological study. Van Reeth K, Nauwynck H, Pensaert M, Vet Microbiol 1996 48 325 335 10.1016/0378-1135(95)00145-X 9054128 (Pubitemid 26090073)
2. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y, J Virol 1998 72 7367 7373 9696833 (Pubitemid 28377868)
3. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Neumann G, Noda T, Kawaoka Y, Nature 2009 459 931 939 10.1038/nature08157 19525932
4. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM, N Engl J Med 2009 360 2605 2615 19423869
5. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. Macklin MD, McCabe D, McGregor MW, Neumann V, Meyer T, Callan R, Hinshaw VS, Swain WF, J Virol 1998 72 1491 1496 9445052 (Pubitemid 28116937)
6. Isolation and genetic analysis of human origin H1N1 and H3N2 influenza viruses from pigs in China. Yu H, Zhang GH, Hua RH, Zhang Q, Liu TQ, Liao M, Tong GZ, Biochem Biophys Res Commun 2007 356 91 96 10.1016/j.bbrc.2007.02.096 17346674 (Pubitemid 46413133)
7. Emergence of avian H1N1 influenza viruses in pigs in China. Guan Y, Shortridge KF, Krauss S, Li PH, Kawaoka Y, Webster RG, J Virol 1996 70 8041 8046 8892928 (Pubitemid 26339113)
8. Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? Peiris JS, Guan Y, Markwell D, Ghose P, Webster RG, Shortridge KF, J Virol 2001 75 9679 9686 10.1128/JVI.75.20.9679-9686.2001 11559800 (Pubitemid 32900102)
9. Genetic evolution of swine influenza A (H3N2) viruses in China from 1970 to 2006. Yu H, Hua RH, Zhang Q, Liu TQ, Liu HL, Li GX, Tong GZ, J Clin Microbiol 2008 46 1067 1075 10.1128/JCM.01257-07 18199784 (Pubitemid 351380002)
10. Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. Richt JA, Lager KM, Janke BH, Woods RD, Webster RG, Webby RJ, J Clin Microbiol 2003 41 3198 3205 10.1128/JCM.41.7.3198-3205.2003 12843064 (Pubitemid 36842322)
11. Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population. Webby RJ, Rossow K, Erickson G, Sims Y, Webster R, Virus Res 2004 103 67 73 10.1016/j.virusres.2004. 02.015 15163491 (Pubitemid 38649062)
12. Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Vincent AL, Lager KM, Ma W, Lekcharoensuk P, Gramer MR, Loiacono C, Richt JA, Vet Microbiol 2006 118 212 222 10.1016/j.vetmic.2006.07.017 16962262 (Pubitemid 44781158)
13. Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs. Bikour MH, Cornaglia E, Elazhary Y, Can J Vet Res 1996 60 312 314 8904668
14. Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy. de Jong JC, Heinen PP, Loeffen WL, van Nieuwstadt AP, Claas EC, Bestebroer TM, Bijlsma K, Verweij C, Osterhaus AD, Rimmelzwaan GF, et al. Vaccine 2001 19 4452 4464 10.1016/S0264-410X(01)00190-6 11483271 (Pubitemid 32718669)
15. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes. Van Reeth K, Gregory V, Hay A, Pensaert M, Vaccine 2003 21 1375 1381 10.1016/S0264-410X(02)00688-6 12615433 (Pubitemid 36263179)
16. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vincent AL, Ciacci-Zanella JR, Lorusso A, Gauger PC, Zanella EL, Kehrli ME, Janke BH, Lager KM, Vaccine 2010 28 2782 2787 10.1016/j.vaccine.2010.01.049 20132919
17. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Chen MW, Cheng TJ, Huang Y, Jan JT, Ma SH, Yu AL, Wong CH, Ho DD, Proc Natl Acad Sci U S A 2008 105 13538 13543 10.1073/pnas.0806901105 18765801
18. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W, Nat Med 1999 5 1157 1163 10.1038/13484 10502819 (Pubitemid 29474420)
19. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Tompkins SM, Zhao ZS, Lo CY, Misplon JA, Liu T, Ye Z, Hogan RJ, Wu Z, Benton KA, Tumpey TM, Epstein SL, Emerg Infect Dis 2007 13 426 435 10.3201/eid1303.061125 17552096 (Pubitemid 46348126)
20. Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret. Rao SS, Kong WP, Wei CJ, Van Hoeven N, Gorres JP, Nason M, Andersen H, Tumpey TM, Nabel GJ, PLoS One 2010 5 9812 10.1371/journal.pone.0009812 20352112
21. Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, Lalor P, Leamy V, Vahle R, Luke CJ, et al. Hum Vaccin 2007 3 157 164 10.4161/hv.3.5.4175 17637571 (Pubitemid 47598172)
22. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Lamb RA, Zebedee SL, Richardson CD, Cell 1985 40 627 633 10.1016/0092-8674(85)90211-9 3882238 (Pubitemid 15076578)
23. Heterologous protection against influenza by injection of DNA encoding a viral protein. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, et al. Science 1993 259 1745 1749 10.1126/science.8456302 8456302 (Pubitemid 23114660)
24. A universal epitope-based influenza vaccine and its efficacy against H5N1. Adar Y, Singer Y, Levi R, Tzehoval E, Perk S, Banet-Noach C, Nagar S, Arnon R, Ben-Yedidia T, Vaccine 2009 27 2099 2107 10.1016/j.vaccine.2009.02.011 19356612
25. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant. Sui Z, Chen Q, Wu R, Zhang H, Zheng M, Wang H, Chen Z, Arch Virol 2010 155 535 544 10.1007/s00705-010-0621-4 20195654
26. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, et al. Nature 2009 460 1021 1025 19672242
27. Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs. Lange E, Kalthoff D, Blohm U, Teifke JP, Breithaupt A, Maresch C, Starick E, Fereidouni S, Hoffmann B, Mettenleiter TC, et al. J Gen Virol 2009 90 2119 2123 10.1099/vir.0.014480-0 19592456
28. Experimental infection of pigs with the human 1918 pandemic influenza virus. Weingartl HM, Albrecht RA, Lager KM, Babiuk S, Marszal P, Neufeld J, Embury-Hyatt C, Lekcharoensuk P, Tumpey TM, Garcia-Sastre A, Richt JA, J Virol 2009 83 4287 4296 10.1128/JVI.02399-08 19224986
29. Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Vincent AL, Lager KM, Faaberg KS, Harland M, Zanella EL, Ciacci-Zanella JR, Kehrli ME, Janke BH, Klimov A, Influenza Other Respi Viruses 2010 4 53 60 10.1111/j.1750-2659. 2009.00121.x 20167045
30. Novel reassortment of Eurasian Avian-like and pandemic/2009 influenza viruses in swine: infectious potential to humans. Zhu H, Zhou B, Fan X, Lam TT, Wang J, Chen A, Chen X, Chen H, Webster RG, Webby R, et al. J Virol 2011
31. Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. Larsen DL, Dybdahl-Sissoko N, McGregor MW, Drape R, Neumann V, Swain WF, Lunn DP, Olsen CW, J Virol 1998 72 1704 1708 9445082 (Pubitemid 28116967)
32. Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine. Luke JM, Simon GG, Soderholm J, Errett JS, August JT, Gale M, Hodgson CP, Williams JA, J Virol 2011 85 1370 1383 10.1128/JVI.01250-10 21106745
33. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e. Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC, Vaccine 2011 29 5481 5487 10.1016/j.vaccine.2011.05.062 21664216
34. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Larsen DL, Karasin A, Olsen CW, Vaccine 2001 19 2842 2853 10.1016/S0264-410X(01)00014-7 11282195 (Pubitemid 32244277)
35. Importance of a prime-boost DNA/protein vaccination to protect chickens against low-pathogenic H7 avian influenza infection. Le Gall-Recule G, Cherbonnel M, Pelotte N, Blanchard P, Morin Y, Jestin V, Avian Dis 2007 51 490 494 10.1637/7592-040206R.1 17494616 (Pubitemid 46671340)
36. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. Heinen PP, Rijsewijk FA, de Boer-Luijtze EA, Bianchi AT, J Gen Virol 2002 83 1851 1859 12124449 (Pubitemid 34846448)
37. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Wang S, Zhang C, Zhang L, Li J, Huang Z, Lu S, Vaccine 2008 26 2100 2110 10.1016/j.vaccine.2008.02.033 18378365
38. A DNA transfection system for generation of influenza A virus from eight plasmids. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG, Proc Natl Acad Sci U S A 2000 97 6108 6113 10.1073/pnas.100133697 10801978 (Pubitemid 30367531)
39. A simple method of estimating fifty per cent endpoints. Reed LJ, Muench HA, Am J Hyg 1938 37 493 497
40. Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design. Liu W, Zou P, Ding J, Lu Y, Chen YH, Microbes Infect 2005 7 171 177 10.1016/j.micinf.2004.10.006 15777646 (Pubitemid 40387421)
41. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein. Bodmer HC, Pemberton RM, Rothbard JB, Askonas BA, Cell 1988 52 253 258 10.1016/0092-8674(88)90514-4 2449284 (Pubitemid 18042859)
42. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Huber VC, McKeon RM, Brackin MN, Miller LA, Keating R, Brown SA, Makarova N, Perez DR, Macdonald GH, McCullers JA, Clin Vaccine Immunol 2006 13 981 990 10.1128/CVI.00156-06 16960108 (Pubitemid 44518965)
43. Selected strategies to augment polynucleotide immunization. Conry RM, Widera G, LoBuglio AF, Fuller JT, Moore SE, Barlow DL, Turner J, Yang NS, Curiel DT, Gene Ther 1996 3 67 74 8929913 (Pubitemid 26084940)
44. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Webster RG, Kawaoka Y, Taylor J, Weinberg R, Paoletti E, Vaccine 1991 9 303 308 10.1016/0264-410X(91) 90055-B 1651609
45. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, Zeng H, Swayne DE, Pantin-Jackwood M, Katz JM, Tumpey TM, J Virol 2010 84 4194 4203 10.1128/JVI.02742-09 20181710